Clinical trials for etanercept biosimilars

posted 22/05/2015

Researchers from the Charité – Universitätsmedizin Berlin, Germany, carried out a systematic review into clinical trials for etanercept biosimilars as part o...

Australian approval for biosimilar insulin Biosimilars/News | Posted 22/05/2015
Variation in biosimilar recombinant streptokinase Biosimilars/Research | Posted 22/05/2015
Patients’ perceptions of HIV generics in France Generics/Research | Posted 22/05/2015
FDA issues another biosimilars Q&A guidance Guidelines | Posted 22/05/2015
US generics manufacturers renew calls for label... Policies & Legislation | Posted 22/05/2015
Generics of high blood pressure medication laun... Generics/News | Posted 22/05/2015
Clinical trials for adalimumab biosimilars Biosimilars/Research | Posted 15/05/2015
Patients’ and physicians’ perceptions of HIV ge... Generics/Research | Posted 15/05/2015
Iran approves its first rituximab biogeneric Biosimilars/News | Posted 15/05/2015
Alternative proposal for generics labelling Policies & Legislation | Posted 15/05/2015
TWi and Takeda settle dispute over anti-reflux... Generics/News | Posted 15/05/2015
Biosimilar filgrastim highly similar to origina... Biosimilars/Research | Posted 08/05/2015
Statin generics improves adherence Generics/Research | Posted 08/05/2015
Clinical trials of biosimilars for psoriasis tr... Biosimilars/Research | Posted 08/05/2015
Biosimilars Forum launched Biosimilars/General | Posted 08/05/2015
Venezuelan approval for Celltrion’s Remsima Biosimilars/News | Posted 08/05/2015
The cost of specialty pharmaceuticals Reports | Posted 08/05/2015
FDA to hold public meeting on GDUFA Guidelines | Posted 08/05/2015
Anticompetitive acquisition forces generics sale Pharma News | Posted 08/05/2015
Biosimilars 20/20 Conferences | Posted 08/05/2015
FDA finalizes biosimilars guidelines Guidelines | Posted 04/05/2015
Brazil approves first monoclonal antibody follo... Biosimilars/News | Posted 04/05/2015
Teva finally makes bid for Mylan Pharma News | Posted 04/05/2015
Considerations when promoting generics prescrib... Biosimilars/Research | Posted 04/05/2015
FDA approves first generics of antipsychotic drug Generics/News | Posted 04/05/2015
Australian guide to biosimilars Biosimilars/General | Posted 04/05/2015
Adalimumab biosimilar meets primary endpoints i... Biosimilars/Research | Posted 04/05/2015
WHO receives positive feedback on BQ for biolog... Biosimilars/General | Posted 27/04/2015
Promoting generics prescribing in the US Biosimilars/Research | Posted 27/04/2015
US health insurance CMS outlines biosimilar policy Policies & Legislation | Posted 27/04/2015
Poland’s experience with generic imatinib Generics/Research | Posted 27/04/2015
Samsung adds 48-week extension to SB4 biosimila... Biosimilars/News | Posted 27/04/2015
Soaring generics prices come under increased sc... Generics/General | Posted 27/04/2015
Generics group established first voice for bios... Biosimilars/General | Posted 27/04/2015
Growing investment in Vietnam Pharma News | Posted 27/04/2015
Arguments for same INN for biosimilars presente... Biosimilars/General | Posted 17/04/2015
More US state legislation on biosimilars substi... Policies & Legislation | Posted 17/04/2015
Safety and cost considerations of generic and o... Generics/Research | Posted 17/04/2015
Substitution of biosimilars in the US Biosimilars/Research | Posted 17/04/2015
IDT Australia gets FDA nod for 23 generics Generics/News | Posted 17/04/2015
Merck outlines biosimilars programme Biosimilars/News | Posted 17/04/2015

Generics News Research General


Biosimilars News Research General